Global Cardiovascular and Soft Tissue Repair Patches Market - 2024-2031

Global Cardiovascular and Soft Tissue Repair Patches Market - 2024-2031

Global Cardiovascular and Soft Tissue Repair Patches market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Cardiovascular and soft tissue repair patches are specialized medical devices that surgeons employ to heal damaged tissues in the heart and other soft tissues throughout the body. These patches serve as a supporting scaffold, encouraging tissue regeneration and restoring function.

These patches are made from biocompatible materials such as synthetic polymers (ePTFE-expanded polytetrafluoroethylene), biodegradable materials (collagen), or a combination of the two. Patches offer structural support to the injured location, allowing surrounding tissues to heal while preventing further difficulties.

Market Dynamics: Drivers & Restraints

Rising prevalence of heart diseases

Cardiovascular diseases (CVDs) are the most prevalent cause of death worldwide, according to the World Health Organisation. Unhealthy lifestyles, aging populations, and rising diabetes rates all contribute to the increased prevalence of cardiac disease. As the number of people diagnosed with heart disease rises, so will the demand for effective treatments. Cardiovascular and soft tissue repair patches provide a minimally invasive, potentially life-saving treatment for a variety of cardiac problems.

For instance, according to the report by the American College of Surgeons in 2024, an estimated 611,000 ventral and 1 million inguinal hernia repairs are performed each year in the US, according to Healthcare Cost and Utilization Project data and the US Food and Drug Administration.

Globally, these surgeries are estimated to top 20 million a year, making hernia repair one of the most commonly performed general surgery procedures in the world. Thus, the above factors are expected to drive the market growth during the forecast period.

High cost of procedures

The high cost of patch-based cardiovascular and soft tissue repair operations could hinder certain patients from obtaining these potentially life-saving therapies. Patients with limited funds may postpone or skip surgeries. It is difficult for hospitals and other healthcare facilities to easily offer these operations due to their high cost, which strains healthcare finances.

For more details on this report – Request for Sample

Segment Analysis

The global cardiovascular and soft tissue repair patches market is segmented based on raw material, application and region.

ePTFE segment is expected to dominate the market growth

ePTFE currently holds a significant share of the market for cardiovascular and soft tissue repair patches owing to its benefits. These patches offer the restored tissue long-lasting support since they are robust and long-lasting. Tissue ingrowth is made possible by ePTFE's microporous structure, which also promotes integration with surrounding tissues and spontaneous healing. As ePTFE patches can be customized to fit a range of sizes and shapes, they can be used for a variety of mending techniques.

Compared to some other materials used in repair patches, ePTFE offers a relatively cost-effective option. As the tissue heals, these substances like collagen are eventually absorbed by the body and can offer some benefits. Because these patches are made of human or animal tissue, their integration with the body's own tissues could be improved. Thus, the above factors are expected to hold the segment in the dominant position during the forecast period.

Geographical Analysis

North America is expected to hold a significant position in the Cardiovascular and Soft Tissue Repair Patches market share

North America has a big and well-developed healthcare infrastructure, as well as a high prevalence of cardiovascular disease. This results in a high demand for cardiovascular and soft tissue repair procedures, especially those involving repair patches. The region is at the forefront of medical technological advances, with significant research and development efforts in the field of cardiovascular repair. This leads to the rapid adoption of new and novel repair patch technologies.

For instance, in May 2024, the Centers for Disease Control and Prevention estimated that Congenital Heart Diseases affect nearly 1% of or about 40,000 births per year in the United States. The prevalence of some heart defects, especially mild types, is increasing.

The most common type of heart defect is a ventricular septal defect. About 1 in 4 babies with a heart defect have a critical heart defect. Infants with critical heart defects generally need surgery or other procedures in their first year of life. Thus, the above factors are expected to drive the market growth during the forecast period. Thus, the above factors are expected to hold the region in the dominant position.

COVID-19 Impact Analysis

The COVID-19 pandemic severely affected the supply and demand networks, manufacturing processes, sales channels, product distribution systems, and the operations of numerous stakeholders in the healthcare industry. The revenue earnings of important participants were significantly reduced by these disruptions. The availability of raw materials and completed patches was impacted by the disruption of the worldwide supply chain caused by lockdowns and travel restrictions. As a result, there were shortages and possible delays in the processes that needed these modifications.

Market Segmentation

By Raw Material
• ePTFE
• Biomaterial and Tissue Engineered Material
• Others

By Application
• Cardiac Repair
• Vascular Repair
• Pericardial Repair
• Dural Repair
• Soft Tissue Repair

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include B. Braun Medical Ltd, W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, Baxter International Inc., Abbott Laboratories, LeMaitre Vascular Inc., CorMatrix, Inc., GETINGE Group, Vascudyne, Inc. and Becton, Dickinson and Company among others.

Why Purchase the Report??
• To visualize the global cardiovascular and soft tissue repair patches market segmentation based on raw material, application and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cardiovascular and soft tissue repair patches market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global cardiovascular and soft tissue repair patches market report would provide approximately 53 tables, 47 figures and 176 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies